Evidence map›Paper›PMID 34076489›Full record

ArticlemBio2021

Mix-and-Match System for the Enzymatic Synthesis of Enantiopure Glycerol-3-Phosphate-Containing Capsule Polymer Backbones from

Christa Litschko, Insa Budde, Monika Berger, Andrea Bethe, Julia Schulze, E Alberto Alcala Orozco, Reza Mahour, Peter Goettig, Jana Indra Führing, Thomas Rexer and 3 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Christa LitschkoInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Insa BuddeInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Monika BergerInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Andrea BetheInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Julia SchulzeInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
E Alberto Alcala OrozcoMax Planck Institute for Dynamics of Complex Technical Systems, Bioprocess Engineering, Magdeburg, Germany.
Reza MahourMax Planck Institute for Dynamics of Complex Technical Systems, Bioprocess Engineering, Magdeburg, Germany.
Peter GoettigDepartment of Biosciences, University of Salzburg, Salzburg, Austria.
Jana Indra FühringInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Thomas RexerMax Planck Institute for Dynamics of Complex Technical Systems, Bioprocess Engineering, Magdeburg, Germany.
Rita Gerardy-SchahnInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Mario SchubertDepartment of Biosciences, University of Salzburg, Salzburg, Austria.
Timm FiebigInstitute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Medizinische Hochschule Hannover · DEMax Planck Institute for Dynamics of Complex Technical Systems · DEUniversity of Salzburg · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Capsule polymers are crucial virulence factors of pathogenic bacteria and are used as antigens in glycoconjugate vaccine formulations. Some Gram-negative pathogens express poly(glycosylglycerol phosphate) capsule polymers that resemble Gram-positive wall teichoic acids and are synthesized by TagF-like capsule polymerases. So far, the biotechnological use of these enzymes for vaccine developmental studies was restricted by the unavailability of enantiopure CDP-glycerol, one of the donor substrates required for polymer assembly. Here, we use CTP:glycerol-phosphate cytidylyltransferases (GCTs) and TagF-like polymerases to synthesize the poly(glycosylglycerol phosphate) capsule polymer backbones of the porcine pathogen Actinobacillus pleuropneumoniae, serotypes 3 and 7 (

Indexed as

Actinobacillus pleuropneumoniaeAnimalsBacterial CapsulesBacterial VaccinesCattleGlycerophosphatesNeisseria meningitidisPasteurellaceaePolymersSheepSwineBacterial VaccinesGlycerophosphatesPolymersanimal healthantibiotic resistancecapsuleenzymatic synthesisglycerolglycoconjugate vaccineglycosyltransferaseNMRpolysaccharidesrecombinant protein expressionTagF-like polymerasesteichoic acidveterinary vaccine development

Identifiers

PMID34076489
PMCPMC8262930
OpenAlexW3165199765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.